These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34460317)

  • 1. Thirty Years of Neuroscientific Investigation of Placebo and Nocebo: The Interesting, the Good, and the Bad.
    Benedetti F; Frisaldi E; Shaibani A
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():323-340. PubMed ID: 34460317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo and nocebo effects: a complex interplay between psychological factors and neurochemical networks.
    Frisaldi E; Piedimonte A; Benedetti F
    Am J Clin Hypn; 2015 Jan; 57(3):267-84. PubMed ID: 25928679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the role of placebo in neurotherapeutics?
    Frisaldi E; Shaibani A; Trucco M; Milano E; Benedetti F
    Expert Rev Neurother; 2022 Jan; 22(1):15-25. PubMed ID: 34845956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding placebo and nocebo effects in the context of sport: A psychological perspective.
    Raglin J; Szabo A; Lindheimer JB; Beedie C
    Eur J Sport Sci; 2020 Apr; 20(3):293-301. PubMed ID: 32023170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Nocebo Effect.
    Colloca L
    Annu Rev Pharmacol Toxicol; 2024 Jan; 64():171-190. PubMed ID: 37585661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating methods and findings from neuroscience to better understand placebo and nocebo effects in sport.
    Beedie C; Benedetti F; Barbiani D; Camerone E; Lindheimer J; Roelands B
    Eur J Sport Sci; 2020 Apr; 20(3):313-325. PubMed ID: 31573836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Placebo and Nocebo Phenomena: Their Clinical Management and Impact on Treatment Outcomes.
    Chavarria V; Vian J; Pereira C; Data-Franco J; Fernandes BS; Berk M; Dodd S
    Clin Ther; 2017 Mar; 39(3):477-486. PubMed ID: 28237673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenase-prostaglandins pathway.
    Benedetti F; Durando J; Vighetti S
    Pain; 2014 May; 155(5):921-928. PubMed ID: 24462931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Placebo and nocebo : How can they be used or avoided?].
    Hansen E; Zech N; Meissner K
    Internist (Berl); 2017 Oct; 58(10):1102-1110. PubMed ID: 28702702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The placebo-nocebo response: controversies and challenges from clinical and research perspective.
    Jakovljevic M
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):333-41. PubMed ID: 24393653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocebo and lessebo effects.
    A Mestre T
    Int Rev Neurobiol; 2020; 153():121-146. PubMed ID: 32563285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European Headache Federation recommendations for placebo and nocebo terminology.
    Mitsikostas DD; Blease C; Carlino E; Colloca L; Geers AL; Howick J; Evers AWM; Flaten MA; Kelley JM; Kirsch I; Klinger R; MaassenVanDenBrink A; Moerman DE; Sfikakis PP; Vase L; Wager TD; Benedetti F;
    J Headache Pain; 2020 Sep; 21(1):117. PubMed ID: 32977761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus.
    Evers AWM; Colloca L; Blease C; Annoni M; Atlas LY; Benedetti F; Bingel U; Büchel C; Carvalho C; Colagiuri B; Crum AJ; Enck P; Gaab J; Geers AL; Howick J; Jensen KB; Kirsch I; Meissner K; Napadow V; Peerdeman KJ; Raz A; Rief W; Vase L; Wager TD; Wampold BE; Weimer K; Wiech K; Kaptchuk TJ; Klinger R; Kelley JM
    Psychother Psychosom; 2018; 87(4):204-210. PubMed ID: 29895014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of the Theoretical and Biological Understanding of the Nocebo and Placebo Phenomena.
    Dodd S; Dean OM; Vian J; Berk M
    Clin Ther; 2017 Mar; 39(3):469-476. PubMed ID: 28161116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurobiological underpinnings of placebo and nocebo effects.
    Benedetti F; Piedimonte A
    Semin Arthritis Rheum; 2019 Dec; 49(3S):S18-S21. PubMed ID: 31779844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the mechanisms of placebo and nocebo effects.
    Frisaldi E; Shaibani A; Benedetti F
    Swiss Med Wkly; 2020 Aug; 150():w20340. PubMed ID: 32920787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo and nocebo effect: a mini-review.
    Požgain I; Požgain Z; Degmečić D
    Psychiatr Danub; 2014 Jun; 26(2):100-7. PubMed ID: 24909245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of contextual factors as triggers of placebo and nocebo effects in musculoskeletal pain.
    Rossettini G; Carlino E; Testa M
    BMC Musculoskelet Disord; 2018 Jan; 19(1):27. PubMed ID: 29357856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do randomized clinical trials with inadequate blinding report enhanced placebo effects for intervention groups and nocebo effects for placebo groups?
    Feys F; Bekkering GE; Singh K; Devroey D
    Syst Rev; 2014 Feb; 3():14. PubMed ID: 24555576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo and nocebo effects in the neurological practice.
    Bittar C; Nascimento OJ
    Arq Neuropsiquiatr; 2015 Jan; 73(1):58-63. PubMed ID: 25608129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.